NICE and drugs for multiple sclerosis. National Institute of Clinical Excellence.
Hartung
H P
HP
D000068717:Glatiramer Acetate; D006801:Humans; D016899:Interferon-beta / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000191:economics; D010455:Peptides / Q000627:therapeutic use*; D013222:State Medicine / Q000331:legislation & jurisprudence; D006113:United Kingdom
D010455:Peptides; D000068717:Glatiramer Acetate; D016899:Interferon-beta